Chordate Medical Holding AB (CMH) — Cash Flow-to-Debt Ratio
Chordate Medical Holding AB (CMH) has a Cash Flow-to-Debt Ratio of -1.72x as of June 2025, meaning its operating cash flow of Skr-7.14 Million could theoretically repay -2% of its total liabilities (Skr4.14 Million) in one year. See how liquid is Chordate Medical Holding AB's working capital to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Chordate Medical Holding AB Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Chordate Medical Holding AB across 10 annual periods. Also explore Chordate Medical Holding AB (CMH) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Chordate Medical Holding AB (2015–2024)
Year-by-year debt coverage analysis for Chordate Medical Holding AB. For market capitalisation and broader financial context, see how much is Chordate Medical Holding AB worth.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.93x | Skr-24.41 Million | Skr8.34 Million | ▲ +26.2% |
| 2023 | -3.97x | Skr-27.26 Million | Skr6.87 Million | ▼ -20.3% |
| 2022 | -3.30x | Skr-24.98 Million | Skr7.57 Million | ▲ +17.0% |
| 2021 | -3.98x | Skr-20.34 Million | Skr5.11 Million | ▼ -27.3% |
| 2020 | -3.13x | Skr-17.43 Million | Skr5.58 Million | ▼ -45.2% |
| 2019 | -2.15x | Skr-16.95 Million | Skr7.87 Million | ▼ -11.7% |
| 2018 | -1.93x | Skr-18.99 Million | Skr9.86 Million | ▼ -10.7% |
| 2017 | -1.74x | Skr-18.99 Million | Skr10.91 Million | ▼ -109.0% |
| 2016 | -0.83x | Skr-9.64 Million | Skr11.58 Million | ▲ +20.3% |
| 2015 | -1.05x | Skr-12.42 Million | Skr11.89 Million | — |